Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics
NCT03237130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133
Last updated 2021-02-02
Summary
This study proposes to establish a CT radiomics-based prediction model for identifying metastasis lymph nodes in esophageal cancer.
Conditions
- Esophagus Cancer
Interventions
- PROCEDURE
-
preoperative enhanced chest CT examination
Each patient will receive preoperative enhanced chest CT examination, and their CT images will be used for analysis
Sponsors & Collaborators
-
Peking University Cancer Hospital & Institute
lead OTHER
Principal Investigators
-
Ying-Shi Sun, MD · Dept.Radiology,Peking University Cancer Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-15
- Primary Completion
- 2019-11-07
- Completion
- 2020-05-15
Countries
- China
Study Locations
More Related Trials
-
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02547610 ·Status: UNKNOWN
-
PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients
NCT05855291 ·Status: COMPLETED ·Phase: NA
-
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
NCT05626127 ·Status: UNKNOWN
-
Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy
NCT01269970 ·Status: COMPLETED
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCC
NCT05287880 ·Status: UNKNOWN
-
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
NCT07331532 ·Status: RECRUITING
-
Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
NCT06203119 ·Status: RECRUITING
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Predicting Esophageal Cancer Borders Using PET-Imaging
NCT06408116 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI
NCT04359732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases
NCT05140083 ·Status: UNKNOWN ·Phase: PHASE1
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
NCT02311556 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Photoacoustic Tomography
NCT03501823 ·Status: UNKNOWN
-
[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
NCT07314073 ·Status: RECRUITING ·Phase: PHASE2
-
Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET
NCT01065818 ·Status: TERMINATED ·Phase: NA
-
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT02527057 ·Status: UNKNOWN
-
Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
NCT04273334 ·Status: UNKNOWN ·Phase: PHASE1
-
Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer
NCT01549379 ·Status: TERMINATED ·Phase: NA
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
NCT06148220 ·Status: RECRUITING ·Phase: NA
-
Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer(RPLNM)(GIPMCS-1701)
NCT03488446 ·Status: UNKNOWN
-
PET-MRI Esophagus Feasibility Study
NCT05796102 ·Status: RECRUITING ·Phase: NA